The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B

Journal of Clinical Gastroenterology

Volumn 46, Issue 6, 2012, Pages 518-525

  Chon, Young Eun ^a   Jung, Eun Suk ^a   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Han, Kwang Hyub ^a,b   Chon, Chae Yoon ^a,b   Jung, Kyu Sik ^a   Kim, Seung Up ^a,b  

^a Yonsei University   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

Author keywords

chronic hepatitis B; decompensation; fibroscan; hepatocellular carcinoma; prediction

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL PERITONITIS; CHRONIC HEPATITIS; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATORENAL SYNDROME; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 84862277495     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31825079f1     Document Type: Article

References (46)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539.
2. Pungpapong S, Kim WR, Poterucha J. Natural history of hepatitis B virus infection: An update for clinicians. Mayo Clinic Proc. 2007;82:967-975.
3. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
4. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32:477-481.
5. Castra L, Ngre I, Samii K, et al. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529-1530.
6. Rousselet M, Michalak S, Dupr F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005;41:257-264.
7. Bedossa P, Dargre D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38: 1449-1457.
8. Wai C, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38: 518-526.
9. Kim BK, Kim SA, Park YN, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969-976.
10. Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44-48.
11. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43: 1317-1325.
12. Kim BK, Han K, Park JY, et al. Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis. Liver Int. 2010;30:860-866.
13. Baranova A, Lal P, Birerdinc A, et al. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 2011;11:91.
14. Sandrin L, Fourquet B, Hasquenoph J, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713.
15. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut. 2006;55:403-408.
16. Ganne-Carri N, Ziol M, De Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44: 1511-1517.
17. Kim SU, Kim DY, Park JY, et al. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol. 2010;44:66-71.
18. Kim BK, Han K, Park JY, et al. A liver stiffness measurementbased, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010; 105:1382-1390.
19. Lee HJ, Seo YS, Kim DJ, et al. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B. J Gastroenterol Hepatol. 2011;26: 987-995.
20. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011;53: 885-894.
21. Masuzaki R, Tateishi R, Yoshida H, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009;49:1954-1961.
22. Kim DY, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci. 2009;54:1758-1763.
23. Kim SU, Han K, Nam CM, et al. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites. J Gastroenterol Hepatol. 2008;23:1722-1727.
24. Dittrich M, Milde S, Dinkel E, et al. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol. 1983;13: 206-211.
25. Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol. 2004;10: 88-98.
26. Liaw YF, Tai DI, Chu CM, et al. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology. 1988;8:493-496.
27. Patch D, Dagher L. Acute variceal bleeding: General management. World J Gastroenterol. 2001;7:466-475.
28. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55(suppl 6):vi1-vi12.
29. Hoefs JC, Canawati HN, Sapico FL, et al. Spontaneous bacterial peritonitis. Hepatology. 1982;2:399-407.
30. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nature reviews. Gastroenterol Hepatol. 2010;7:515-525.
31. Gins P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol. 1999;10:1833-1839.
32. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
33. Minagawa M, Ikai I, Matsuyama Y, et al. Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909-922.
34. Kim SU, Park JY, Kim DY, et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: Impact of antiviral treatment on fibrosis regression. Hepatol Int. 2010;4:673-680.
35. Guha IN. Back to the future with noninvasive biomarkers of liver fibrosis. Hepatology. 2009;49:9-11.
36. Kim BK, Han K, Park JY, et al. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver Int. 2010;30:1073-1081.
37. Castra L, Foucher J, Bernard P, et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828-835.
38. Kim SU, Han K, Ahn SH. Transient elastography in chronic hepatitis B: An Asian perspective. World J Gastroenterol. 2010;16:5173-5180.
39. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
40. Liaw YF, Lin DY, Chen TJ, et al. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Liver. 1989;9:235-241.
41. Shariff MI, Cox IJ, Gomaa AI, et al. Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 2009;3:353-367.
42. Aub C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol. 1999;30:472-478.
43. Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45: 1290-1297.
44. Carrin JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006;12:1791-1798.
45. Fung J, Lai CL, Wong DK, et al. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. J Viral Hepat. 2011;18: A200-e205.
46. Osakabe K, Ichino N, Nishikawa T, et al. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol. 2011;46:1324-1334.